Video

Impact of Provider Status on Health-System Pharmacists

Joseph Hill, MA, director of federal legislative affairs for ASHP, explains how provider status would impact health-system pharmacists' daily practice.

Joseph Hill, MA, director of federal legislative affairs for ASHP, explains how provider status would impact health-system pharmacists' daily practice.

This interview was recorded at the ASHP 2014 Midyear Clinical Meeting in Anaheim, California.

Related Videos
Related Content
Stethoscope on US dollar bills | Image Credit: © Kuzmick - stock.adobe.com
March 14th 2025

Executive Order Advances Price Transparency Efforts to Lower Health Care Costs

Alexandra Gerlach, Associate Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Young girl with allergic reaction -- Image credit: Kwangmoozaa | stock.adobe.com
March 14th 2025

Oral Immunotherapy Can Play Key Role in Food Allergy Management in Preschool-Aged Patients

Gillian McGovern, Associate Editor
Pharmacy Focus: GLP-1 Medications and Pharmacists' Role in Counseling Patients
January 31st 2025

Pharmacy Focus: GLP-1 Medications and Pharmacists' Role in Counseling Patients

Luke Halpern, Assistant Editor
Image credit: VadimGuzhva | stock.adobe.com
March 14th 2025

Patients With Type 1 Diabetes Have Reduced Cardiovascular Event Rates Compared With T2D

Kennedy Ferruggia, Assistant Editor
biosimilar word or concept represented by wooden letter tiles on a wooden table with glasses and a book - Image credit: lexiconimages | stock.adobe.com
March 14th 2025

As Biosimilar Substitutions Become More Common, Education and Patient Counseling Are Paramount

Luke Halpern, Assistant Editor